insights_auto
Why is SABS down ၃.၄၂%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
၃.၃၉ US$
arrow_downward
-၃.၄၂%(-၀.၁၂) 1D
၃.၄၄ US$
arrow_upward
+၁.၄၇% (+၀.၀၅၀)bedtimeAfter hours
Closed: စက် ၂၁, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
၃.၅၁ US$
High
၃.၅၅ US$
Low
၃.၃၉ US$
Mkt. cap
၃၀.၈၄ ကုဋေ
Avg. vol.
၃.၆၆ သိန်း
Volume
၃.၇၉ သိန်း
52-wk high
၅.၁၅ US$
52-wk low
၁.၈၅ US$
EPS
-၀.၆၃ US$
Beta
၀.၅၃
Shares outstanding
၉.၁၀ ကုဋေ
No. of employees
၈၆
Open
၃.၅၁ US$
High
၃.၅၅ US$
Low
၃.၃၉ US$
Mkt. cap
၃၀.၈၄ ကုဋေ
Avg. vol.
၃.၆၆ သိန်း
Volume
၃.၇၉ သိန်း
52-wk high
၅.၁၅ US$
52-wk low
၁.၈၅ US$
EPS
-၀.၆၃ US$
Beta
၀.၅၃
Shares outstanding
၉.၁၀ ကုဋေ
No. of employees
၈၆
News stories
From web sources and news partners
CarePlus VietNam
·
ပြီးခဲ့သည့် ၁ လ
SABS Q2 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline - Revenue Per Share
CarePlus VietNam
·
ပြီးခဲ့သည့် ၂ လ
SABS Q1 2026 Earnings: EPS Misses Street Estimates as Pre-Revenue Biotech Continues Pipeline Progress
About SAB Biotherapeutics Inc
CEO-
Employees၈၆
Founded၂၀၁၄
HeadquartersMiami Beach, ဖလော်ရီဒါပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitesab.bio